Serbia agrees to test Chinese vaccine

The China National Biotech Group (CNBG) and the company Sinovac Biotech Ltd. announced that additional countries, including Serbia as well, have agreed to participate in the third phase of clinical trials of their coronavirus vaccines, Reuters agency reports.

Serbia and Pakistan are among countries that have agreed to participate in the third phase of testing, while Chinese companies are asking for more data from abroad for final approvals of a potential vaccine, as decreasing number of new infections in China makes this country an unsatisfactory place for testing, according to Reuters.

In order to obtain a permit for mass use of vaccines, pharmaceutical companies must prove that they are safe and efficient enough, based on the data collected in the extensive third phase of clinical trials, the British agency reminds.

China has already allowed two CNBG vaccines and one vaccine produced by Sinovac to be given to limited groups of people who face a higher risk of infection, such as medical workers.

Both CNBG vaccines will be tested in Serbia, while Pakistan will test a vaccine developed by the Beijing subsidiary of that company, CNBG Vice President Zhang Yuntao stated with Reuters.

Izvor: N1

Foto: Pixabay